Behind the Breakthrough: Q&A with Chris Johnson, Founder and CEO of Bluebird Kids Health

After helping advance value-based care for older adults as the CEO of Landmark Health, Johnson saw an opportunity to bring a similar model to children: a value-based pediatric primary care platform.

Bluebird Kids Health was born from a stark realization for CEO Chris Johnson: nearly half of America’s children receive care through Medicaid or CHIP, but many live in what he calls “pediatric care deserts” – communities where kids are far more likely to end up in the ER, because they can’t easily access primary care.

Johnson discusses why he’s bringing value-based care to pediatrics and how Bluebird is confronting structural inequities in children’s health. He also explores what it means to build a company designed not just to treat illness, but to help every child reach their full potential through equitable health care – one community at a time.

Was there a defining moment that crystalized the need for Bluebird?

Across metro areas, the lowest-income communities have only half as many pediatricians per thousand children as the highest-income zip codes. Many practices can only afford to have around 20% of their patients on Medicaid, which creates barriers to preventative care for millions of children. We set out to close that gap with an integrated model that brings physical, behavioral, and social services under one roof. Bluebird uses technology to make care more consistent and scalable, while aligning patient outcomes with payer incentives and reinvesting to expand services in pediatric care deserts.

Your mission statement is “to provide exceptional care so all children can thrive.” What does that look like day by day?

For us, exceptional care begins by giving our providers the support they need to practice at the peak of their ability. We invest in training, technology, and team-based support, allowing providers to focus on families and not paperwork. It means partnering with behavioral health providers and community organizations to fill social care needs that fall outside traditional medicine.

The “Every Child” aspect means we never want to turn away a child who comes to our door.  We contract with all health plans and offer a self-pay option to ensure every family can access care. We identify primary care deserts by running analytics to pinpoint areas where children have limited access to pediatric practices. In areas with the greatest need, we open clinics in retail spaces (e.g., near grocery stores or laundromats) to meet families “in the flow” of daily life, with extended evening and weekend hours.

Finally, “so all children can thrive” is our long-term measure of success. We aim to create more happy, healthy days for kids. It’s not just about clinical outcomes. It’s about helping children stay in school because they’re now getting the care they need or catching vision issues early to support them as they learn to read. Ultimately, it is about building the foundation for lifelong health.

You brought value-based care principles from adulthood into pediatrics. Why hasn’t this been done before – and why now?

Sometimes problems persist simply because no one has really focused on them. In 1987, only about 16% of children in the U.S. were covered by Medicaid; today, that number exceeds 50%. That means more than half of America’s pediatric population now relies on a system that has historically lacked the innovation and coordinated care models seen in adult medicine. Millions of children still face inequitable access despite having insurance coverage. It’s a massive and growing need, and it’s time the innovation ecosystem caught up to it.

You applied lessons from Landmark Health to this new model. What are some of the biggest takeaways?

The biggest lesson was that you need a mission-aligned culture that truly believes in doing what’s right for patients, paired with a business model that rewards it. When those align, everything else follows.

We’ve also leaned heavily into technology and AI at Bluebird. At Landmark, we used technology because we had to, mainly to process claims and manage data. At Bluebird, we see technology as a driver of the experience itself. We’re building what we call a “pediatric operating system,” which is AI-enabled infrastructure made specifically for this population. It makes back-end operations more efficient and the front-end experience more consistent, from the parent app to the clinical workflow.

What’s your approach to growth, and where do you go from here?

We’re currently operating six Bluebird clinics and expect several more by year’s end. We plan to continue expanding in Florida, then into new states. Our goal is to go deep and truly integrate into communities. In a place like Tampa, for example, we’d rather build half a dozen practices so we can truly serve as a meaningful part of the local health infrastructure and be a reliable partner to hospitals and OBs. Instead of opening a single location in many markets, we focus on building multiple practices within a city so we can become embedded in the community and part of the local health ecosystem.

You’ve mentioned technology as a differentiator. How is AI changing your model?

We use AI to streamline areas across the organization. Things like scheduling, insurance verification, and revenue cycle management become far more efficient with AI, allowing our teams to focus more time and energy on patients. On the care side, we leverage data and analytics to identify children who need proactive interventions, such as closing preventive care gaps. We are also designing digital care management tools that support parents at home.

The key for successfully using AI is integrating it intelligently into the workflow to actually drive outcomes, which is what we’re building our systems to do.

Looking ahead to 2030, what impact do you hope Bluebird will have?

Our north star is to be a meaningful contributor to the health and well-being of children in every community we enter. If you look at why the U.S. lags other wealthy countries in life expectancy, most of that gap actually stems from outcomes for people under 18.

We want to help change that trajectory by reducing preventable mortality, improving health equity, and supporting children as they grow into healthy adults. That’s what “so all children can thrive” truly means for us.

Almanac Health

Almanac Health is a clinical AI platform that brings specialist-grade knowledge to clinicians at the point of care — providing evidence-based clinical decision support across medical specialties, free from pharmaceutical advertising, and governed by institutional controls. The platform integrates with existing EHR systems and is clinically validated through peer-reviewed research. Almanac Health was founded by Cyril Zakka, MD, author of one of NEJM AI’s most-cited papers on retrieval-augmented generation for clinical medicine.

Alder

Alder offers expert, hands-on support for families navigating the complexities of aging. Alder is a team of experienced social workers and nurses helping families navigate the complexities of aging with compassion, clarity, and hands-on support.

Nikhil Marathe

Nikhil is a Principal at F-Prime, where he spearheads the firm’s efforts in healthcare growth equity. His primary focus is to partner with rapidly growing, capital efficient businesses in healthcare software and services.

Prior to joining F-Prime, Nikhil worked at Juxtapose, a creation-oriented investment firm focused on healthcare and technology, where he spent 2 years incubating a new business venture in the pharmaceutical services ecosystem. Prior to Juxtapose, Nikhil spent 13 years at Silversmith Capital Partners and TA Associates, where he closed 12 growth-stage investments across healthcare and enterprise software. He began his career as a technology investment banker at Evercore.

Nikhil has a BS in Economics from The Wharton School at the University of Pennsylvania, with concentrations in Finance and Management.

Behind the Breakthrough: Q&A with Kai Eberhardt, CEO and Co-founder of Oviva

Kai Eberhardt transformed a personal cancer diagnosis in his twenties into a lifelong commitment to improving patient empowerment and healthcare accessibility.

Diagnosed with cancer in his early twenties, Kai Eberhardt quickly learned how disheartening it can feel to navigate the healthcare system without information or agency. That experience became a transformational force, first pushing him toward deeper medical knowledge, then through a PhD in medical physics, and ultimately into the business of healthcare.

He co-founded Oviva in 2014 with engineer Manuel Baumann to confront one of the most widespread, but underserved, health challenges in society: chronic weight-related conditions (such as obesity and type 2 diabetes). Despite the abundance of clinical evidence showing that behavior change and lifestyle interventions can be highly effective, few systems were designed to deliver them at scale, and even fewer offered sustained, patient-centric care accessible to everyday lives.

Eberhardt and his team saw an opportunity to reimagine care delivery, starting with something simple: a secure, compliant chat app connecting patients and their care teams. Over time, that communication layer evolved into Oviva’s full-stack digital care platform, now used by more than one million patients across the UK and Europe.

On the heels of Oviva’s expansion into cardio-metabolic conditions, and after nearly a decade of building credibility and capability in systems like the National Health Service (NHS), Eberhardt shares what it takes to turn frustration into innovation, how the company is scaling with purpose, and why technology is only one part of the solution.

What gap in the healthcare system were you aiming to address in founding Oviva?

The idea for Oviva emerged from a common challenge in obesity treatment—most patients don’t continue treatment after one or two visits. It just isn’t practical for patients to regularly attend sessions in-person despite a demand for care.

What stood out was that these same patients were always on their phones, and unlike other areas of care, weight management doesn’t require physical exams, lab work, or imaging. It largely includes education, coaching, and real-time support. So, we asked: what if we digitized the same care that we provided in-person and delivered it on their phones, anytime, anywhere? That would make it dramatically more accessible, and likely more effective, too.

Can you talk more about how this model helps address affordability and equity?

People managing chronic conditions often juggle jobs, childcare, daily stress – and weight-related health is important, but not always urgent. That makes it easy to de-prioritize care, especially when it requires a visit to a doctor’s office on a random Wednesday afternoon.

Making care available on your phone, on your own schedule, changes everything. For example, look at the NHS Diabetes Prevention Programme – about 20% of people completed the in-person model, but closer to 70% completed Oviva’s digital version. That’s a massive difference.

Virtual care also opens the door to serving culturally and linguistically diverse communities. With digital delivery, you can tailor the content, language, and nutrition guidance for many different patients.  Curating care is almost impossible to do well in a one-size-fits-all, in-person group setting.

You integrate clinical, nutritional, and psychological care. What makes that approach so essential?

Obesity is multifactorial – you just can’t treat it through one lens. Some people need help with nutrition education, some have complex psychological patterns or trauma, and now we also have powerful medications that should be managed by doctors. No one discipline can cover it all.

Not every patient needs every service, but having a full stack available is essential to delivering effective care. We learned this from the best in-person programs –where coordination across teams made all the difference, though it was resource-intensive and hard to sustain. By operating digitally, we can bring those same multidisciplinary perspectives together without the limits of geography or scheduling.

What makes Oviva truly different from other players in your space?

We’re with our patients every day. That’s the biggest difference. Face-to-face models might give you 30 minutes with a clinician once a month. We’re a daily companion – logging meals, giving feedback, coaching, and support throughout the day. That consistency leads to better outcomes.

We’ve published more than 90 papers showing that we outperform in-person care, and because we’re digital, we can do it at lower cost and with broader reach. We’re essentially industrializing something that used to be artisanal – making personalized, behavior-change therapy highly scalable.

Regarding Oviva’s role within the NHS – what does it take to build innovation and credibility in a system as rigorous and complex as that one?

Evidence, first and foremost. I’ve always believed in backing up what we do with strong data, while publishing results publicly to build trust and demonstrate transparency.

After that, it’s about communication – having the skills and patience to speak to very different stakeholders across the NHS. And finally, it’s about partnership. We don’t try to replace services; we instead think about how we can add value to the system through better access and efficiency. This mindset helps us prove we’re here for the long haul.

You have talked about being driven by your own personal experiences in the healthcare space. Can you share how that energy helped shape your journey as a founder?

I’ve always been a pretty intense and action-oriented person. Frustration, for me, serves as a powerful motivator because it offers clarity and urgency. I don’t sit still when I see something broken. I’m not afraid to make decisions or move fast. I think that drive helped me do something many would consider irrational – starting a health tech company from the ground up in a pretty complex space.

Obesity is a field that often carries judgment or stigma. How do you lead with compassion and evidence in that environment?

Honestly, that’s one of the most fulfilling parts of what we do. Many of our patients haven’t received good care before – they’ve been judged or dismissed by the system. When we help them see real progress, it’s incredibly rewarding.

It’s not just for the patient’s benefit either. We’ve shown, with data, that our program reduces patient sick days by about a third within six months. That translates to added productivity in the workplace, tax revenue, and long-term cost savings – things that help the entire system. So, when people ask if this population is “worth investing in,” our results make the answer abundantly clear.

What advice would you give to other founders trying to build something in or alongside a public health system?

You need grit. It takes a long time to get through validation, adoption, and scaling inside a system like the NHS. The process can be very frustrating, especially when you know your solution could help people immediately, but adoption takes time.

Some delays are for good reasons, like needing strong evidence. Other delays are due to competing interests or systemic inertia. You must keep showing up and pushing forward. The reward is that once you’re in, and your model works, it’s incredibly sticky and impactful.

What excites you the most about what’s coming next?

We’re about to launch our hypertension solution, pending final regulatory approvals. It’s been in the works for two years and is a huge opportunity to build something that serves both patients and doctors more effectively – especially in how we manage data, daily insights, and ongoing support between visits.

The role of AI in all of this is just getting started. Our AI-first care model has the potential to transform patient support, making delivery more efficient and effective. We can provide even better continuity of care between doctor visits and better inform doctors for those visits. Since the ChatGPT moment, we’ve been embedding more AI features into our product, making care more scalable and improving outcomes. AI technology and Oviva are evolving rapidly – and I can’t wait to see how far we can go.

Olivia Carlson

Olivia Carlson is a Senior Associate at F-Prime, focusing on investments in healthcare technology and services companies. Prior to joining F-Prime, she was an investor at M33 Growth, where she assessed investment opportunities and supported their portfolio of growth-stage healthcare companies. Olivia also worked in strategy consulting for EY-Parthenon’s healthcare team. She started her career as a certified nursing assistant, working for a home health and hospice company throughout college.

Olivia holds a B.A. from Williams College, where she majored in Pre-Medical Studies and Psychology.

F-Prime’s Summer Internship and Fellowship Program: Meet Our 2025 Interns and Fellows

A big thank you to our interns and fellows for their valuable contributions this summer!

This summer, F-Prime was excited to welcome a talented group of interns and fellows to our Cambridge and London offices. They played key roles in competitive landscape analysis, sourcing, founder calls, and more. Read on to discover what it’s like to be part of our internship and fellowship programs.

 

“This experience has deepened that interest, especially seeing how these tools might fit into real business contexts like VC. Listening to discussions where those kinds of possibilities are explored has also been hugely motivating. ”

 

“The work is creative. I expected rigorous diligence, but I didn’t anticipate how much of the job involves pattern recognition, storytelling, and forming contrarian but grounded views on where a field is heading. You’re constantly toggling between scientific depth and high-level strategic vision.”

 

“I am most surprised by how fast-paced and rapidly evolving the job is. The team has many new calls every day, while also having to study new technologies, keep up with the news, and manage the portfolio companies. I am learning a great deal about how to manage all these aspects of being a venture capitalist.”

 


“I have come to further appreciate how the venture framework is about asking the right questions rather than having all the answers. The best investors seem to pair scientific curiosity with disciplined judgment, which has given me a deeper appreciation for how to approach underwriting risk.”

 


“One thing that stood out is how hands-on and multidimensional the team is at every level. I expected sharp and high-level strategic thinking from partners, but it was refreshing to see just how engaged they are in the details; in every meeting, building models, debating sourcing strategies, refining TAMs.

 


“I was most surprised by the rapid pace of innovation and how quickly the team collaborates to evaluate and act on exciting new opportunities. I also learned how important building relationships are in the VC world. it’s not only about finding good investments but also about fostering long-term relationships with founders and industry leaders.”

 


“I learned about F-Prime through a family friend. I decided to join as an intern because F-Prime gets to work with amazing biotech startups and help them grow as a business. Additionally, the culture at F-Prime is extremely friendly and everyone at the firm wants to help you be the best version of yourself.”

 

Applications for our 2026 program are not open yet, but if you are interested in learning more, please send an email to careers@fprimecapital.com.

From Shortages to Scale: Specialty Care in the AI Era

AmplifyMD’s $20M Series B fuels platform for scalable virtual specialty care.

We spend $1 of every $5 in the U.S. economy on healthcare. That’s exorbitant compared to most developed countries, where people live longer than we do at half the cost. Perverse incentives continue to drive unsustainable cost growth, with employer plans expected to grow by more than 9% in 2026. Our current model reduces employee take-home pay and saddles future generations with added debts to pay for today’s inefficient, fragmented system.

We need startups to clean up this unmanageable mess. To disrupt the current system, entrepreneurs must challenge health oligopolies (e.g., insurance carriers, PBMs, health systems) and chip away at the economic rent extracted by overpaid intermediaries (e.g., brokers, provider contractors, revenue cycle vendors). They also must build new platforms to enable efficient care delivery, powered by AI.

Provider shortages abound because the medical profession has long operated under an oligopoly and guild mentality, limiting the number of new physicians trained each year. Fortunately, technology now allows vastly more efficient distribution of provider time and talent, which could ultimately reverse the expected scarcity. The pandemic proved that care can be delivered effectively in virtual settings, despite primitive tools. As data has also become more portable, we may finally see the end of an era where provider systems hoard data to keep patients in high-cost settings and preserve unfair pricing power. Advances in software now allow “systems of engagement” to interface seamlessly with legacy “systems of record.” This opens the door to disrupting EHR monoliths and creating “new moats,” with AI poised to inject powerful new capabilities into outdated infrastructure.

These shifts create fertile ground for new platforms built for a digital-first, data-rich era, representing a new digital care architecture. AmplifyMD is one such platform – and today we’re thrilled to announce its $20M Series B financing. As an AmplifyMD director, I’ve seen firsthand how its EHR-integrated, AI-enabled virtual care platform helps health systems extend scarce physician capacity and drive material operational efficiencies. AmplifyMD allows specialists to practice anywhere, virtually treating patients in acute care settings and beyond, via its state-of-the-art platform. What began as a solution to expand specialist access in underserved settings has become a systemwide coverage solution trusted by some of the nation’s largest health systems—enabling physicians to extend their expertise without geographic limits.

The age of AI will further transform AmplifyMD’s product into an essential aspect of efficient and effective care delivery. The advent of superintelligent AI in medicine presents a golden opportunity for “creative destruction” to take root, but its potential requires modern platforms like AmplifyMD, which shift workflows from the in-person setting to always-on digital infrastructure. AI can enhance productivity and quality through clinical decision support today, and over time, may enable increasingly autonomous care delivery. This will give patients a greater ability to participate in decisions while receiving tailored treatment plans.

In the modern architecture of care delivery, AI agents will likely evolve to do the heavy lifting for all of us, freeing providers to focus on the highest leverage moments. With innovations like AmplifyMD’s platform, powered by this new financing, the industry can move toward greater access to high-quality care – an important step toward a system that respects our limits today while unlocking our innovative potential for tomorrow.

 

Axle Health

Axle Health is a healthcare technology company on a mission to revolutionize home-based care delivery through its comprehensive operations platform. Founded in 2020 by healthcare and technology veterans, including several former Uber executives who brought their logistics expertise to the healthcare industry, Axle Health’s AI-powered logistics platform enables healthcare organizations to efficiently deploy clinicians for in-home visits, improving patient outcomes while reducing operational costs. The company is headquartered in Los Angeles, California.

Gold-standard Eating Disorder Treatment Delivers Lasting Recovery for Patients and Families at Home

In 2019, Kristina Saffran and Dr. Erin Parks came to us with a slide deck and a passion for helping those struggling with eating disorders (EDs).

We were drawn to their story and mission as many of our team members had been touched by EDs – either suffering from one themselves or having a loved one who had struggled with an ED. Some are surprised to learn that EDs are the most expensive and one of the deadliest behavioral health conditions in the U.S., second only to opioid addiction. Nearly 30 million Americans across all races, genders, body sizes, and sexual orientations will have an eating disorder in their lifetime. Despite their prevalence, only 20% of those struggling receive treatment, and even less have access to evidence-based treatment. Our shared commitment to address this critical treatment gap, coupled with our strong belief in Kristina and Erin, led to our partnership with Equip.

We were delighted to lead the seed round that helped bring Kristina and Erin’s vision to life and to support them through the early fundamentals of company creation, including advising them through decisions about how to incorporate the company. Our team also had the pleasure of helping name the company – we proposed “Equip” during the naming process, believing that it reflected the ethos of the company. Equip – based on equipe, meaning “team” in French and the idea that the company has a strong focus on helping patients figure out how to equip themselves with skills to turn to instead of harmful behaviors. One of our team members, Brooke Hammer, even ultimately joined the company as a key member of the leadership team.


“F-Prime was one of our original champions who truly allowed Equip’s bold vision to become a reality. We, and the eating disorder field, are forever grateful for them.”

Kristina Saffran, CEO and Co-founder


Equip is positioned to transform eating disorder treatment with compelling evidence that their clinical approach works for lasting recovery. A remarkable 96% of Equip’s patients on a weight restoration program are gaining weight, 7 out of 10 are seeing reduction in their ED symptoms and 80% of parents have reported an increased confidence in their ability to address their child’s ED.

Eating disorder treatment is complex and cannot be one-size-fits-all. Equip’s medical and behavioral health platform is built to meet patients and families where they are through virtual family-based therapy (FBT). There are still significant challenges in the space but Equip is leading the way to deliver accessible, effective, fully virtual care.